title: Calcium channel blockers and dementia.
abstract: Degenerative dementia is mainly caused by Alzheimer's disease and/or cerebrovascular abnormalities. Disturbance of the intracellular calcium homeostasis is central to the pathophysiology of neurodegeneration. In Alzheimer's disease, enhanced calcium load may be brought about by extracellular accumulation of amyloid-β. Recent studies suggest that soluble forms facilitate influx through calcium-conducting ion channels in the plasma membrane, leading to excitotoxic neurodegeneration. Calcium channel blockade attenuates amyloid-β-induced neuronal decline in vitro and is neuroprotective in animal models. Vascular dementia, on the other hand, is caused by cerebral hypoperfusion and may benefit from calcium channel blockade due to relaxation of the cerebral vasculature. Several calcium channel blockers have been tested in clinical trials of dementia and the outcome is heterogeneous. Nimodipine as well as nilvadipine prevent cognitive decline in some trials, whereas other calcium channel blockers failed. In trials with a positive outcome, BP reduction did not seem to play a role in preventing dementia, indicating a direct protecting effect on neurons. An optimization of calcium channel blockers for the treatment of dementia may involve an increase of selectivity for presynaptic calcium channels and an improvement of the affinity to the inactivated state. Novel low molecular weight compounds suitable for proof-of-concept studies are now available.
authors: Neuroscience Research, GPRD, AbbVie GmbH, Ludwigshafen, Germany. volker.nimmrich@abbott.com
authors: V
authors: V
authors: Nimmrich
authors: A
authors: A
authors: Eckert
mesh_terms: D000544:Alzheimer Disease / Q000188:drug therapy / Q000378:metabolism / Q000503:physiopathology; D016229:Amyloid beta-Peptides / Q000378:metabolism; D000818:Animals; D001921:Brain / Q000187:drug effects / Q000378:metabolism; D002121:Calcium Channel Blockers / Q000627:therapeutic use*; D015220:Calcium Channels / Q000737:chemistry / Q000378:metabolism*; D020746:Calcium Channels, L-Type / Q000737:chemistry / Q000378:metabolism; D020013:Calcium Signaling / Q000187:drug effects*; D003704:Dementia / Q000188:drug therapy* / Q000378:metabolism / Q000503:physiopathology; D018450:Disease Progression; D015507:Drugs, Investigational / Q000627:therapeutic use; D006801:Humans; D009474:Neurons / Q000187:drug effects / Q000378:metabolism; D018697:Nootropic Agents / Q000627:therapeutic use*; D009435:Synaptic Transmission / Q000187:drug effects
chemical_list: D016229:Amyloid beta-Peptides; D002121:Calcium Channel Blockers; D015220:Calcium Channels; D020746:Calcium Channels, L-Type; D015507:Drugs, Investigational; D018697:Nootropic Agents
references: Neurobiol Dis. 2011 Jan;41(1):62-70
references: 20816785
references: J Biol Chem. 2000 Feb 18;275(7):4713-8
references: 10671502
references: Ann Neurol. 1991 Sep;30(3):381-90
references: 1952826
references: J Neurosci. 2008 Jan 23;28(4):788-97
references: 18216187
references: Mol Med. 2011 Mar-Apr;17(3-4):149-62
references: 21170472
references: Biochem Biophys Res Commun. 2002 Sep 6;296(5):1317-21
references: 12207918
references: Int Rev Neurobiol. 1997;40:95-108
references: 8989618
references: J Neurochem. 1994 Jan;62(1):372-5
references: 8263540
references: Exp Neurol. 2009 Dec;220(2):230-3
references: 19815009
references: Brain Res. 1997 Nov 21;776(1-2):140-5
references: 9439806
references: Biochemistry. 2009 Mar 10;48(9):1870-7
references: 19216516
references: Cell Calcium. 2011 Mar;49(3):184-90
references: 21349580
references: Prog Neurobiol. 2009 Nov;89(3):240-55
references: 19664678
references: Neurobiol Dis. 2008 May;30(2):212-20
references: 18353662
references: J Neurochem. 2006 Sep;98(5):1400-10
references: 16771827
references: J Pharmacol Exp Ther. 2010 Aug;334(2):545-55
references: 20439438
references: Neuropharmacology. 2002 Dec;43(8):1289-96
references: 12527478
references: Lancet Neurol. 2003 Feb;2(2):89-98
references: 12849265
references: Br J Clin Pharmacol. 2012 Apr;73(4):504-17
references: 22035455
references: Proc Natl Acad Sci U S A. 2006 Mar 28;103(13):5161-6
references: 16549764
references: Eur J Pharmacol. 1996 Sep 12;311(2-3):293-304
references: 8891612
references: J Neurophysiol. 2003 Jun;89(6):3061-9
references: 12611943
references: J Neurosurg. 2000 Nov;93(5):829-34
references: 11059665
references: Brain Res. 2002 Jun 7;939(1-2):65-75
references: 12020852
references: Neurobiol Aging. 2005 Feb;26(2):157-63
references: 15582745
references: Nature. 1993 Jan 7;361(6407):31-9
references: 8421494
references: Nat Neurosci. 2009 Dec;12(12):1567-76
references: 19935655
references: Life Sci. 1997;61(21):2083-90
references: 9395249
references: Arzneimittelforschung. 1985;35(12):1787-94
references: 4096730
references: Behav Brain Res. 2008 Sep 1;192(1):106-13
references: 18359102
references: J Neurol. 1997 May;244 Suppl 2:S3-14
references: 9178165
references: Neurobiol Aging. 1989 Sep-Oct;10(5):593-602
references: 2554168
references: Pflugers Arch. 1995 Nov;431(1):10-9
references: 8584405
references: Science. 2002 Jul 19;297(5580):353-6
references: 12130773
references: Science. 1992 Apr 10;256(5054):184-5
references: 1566067
references: J Biol Chem. 2003 Mar 28;278(13):11612-22
references: 12499373
references: Cochrane Database Syst Rev. 2002;(3):CD000147
references: 12137606
references: Arch Neurol. 2009 Mar;66(3):343-8
references: 19273753
references: J Neurochem. 2007 Jun;101(5):1172-84
references: 17286590
references: Curr Top Med Chem. 2009;9(4):377-95
references: 19442208
references: Neurosci Lett. 1992 Jul 20;141(2):199-202
references: 1436634
references: Nature. 2002 Apr 4;416(6880):535-9
references: 11932745
references: Pharm Unserer Zeit. 2005;34(5):392-8
references: 16180362
references: J Alzheimers Dis. 2001 Oct;3(5):479-483
references: 12214034
references: Neuroepidemiology. 1998;17(1):2-9
references: 9549718
references: N Engl J Med. 2010 Jan 28;362(4):329-44
references: 20107219
references: J Neurochem. 1997 Jan;68(1):265-71
references: 8978734
references: J Neurochem. 2001 May;77(3):953-6
references: 11331424
references: Aging Cell. 2007 Jun;6(3):267-73
references: 17517038
references: Brain Res. 2002 Nov 29;956(2):254-61
references: 12445693
references: Dis Model Mech. 2011 Sep;4(5):634-48
references: 21596710
references: J Cereb Blood Flow Metab. 1991 Sep;11(5):771-8
references: 1874809
references: Cell Calcium. 2010 Feb;47(2):183-9
references: 20080301
references: Arch Intern Med. 2002 Oct 14;162(18):2046-52
references: 12374512
references: Eur J Pharmacol. 2006 Sep 1;545(1):11-21
references: 16887118
references: Rev Neurosci. 2009;20(1):1-12
references: 19526730
references: Int J Epidemiol. 1991 Sep;20(3):736-48
references: 1955260
references: Biochem Pharmacol. 2012 Feb 1;83(3):406-18
references: 22153861
references: J Neurol Sci. 2002 Nov 15;203-204:7-10
references: 12417349
references: Rev Neurosci. 2000;11(4):329-82
references: 11065280
references: Mol Cells. 2011 Sep;32(3):289-94
references: 21822937
references: Clin Exp Hypertens. 2008 Nov;30(8):744-66
references: 19021025
references: Int J Geriatr Psychiatry. 2007 Dec;22(12):1264-6
references: 18033677
references: Neuroreport. 1998 Feb 16;9(3):539-45
references: 9512403
references: Lancet. 1998 Oct 24;352(9137):1347-51
references: 9802273
references: J Neurosci. 2007 Mar 14;27(11):2866-75
references: 17360908
references: J Alzheimers Dis. 2004 Jun;6(3):243-55
references: 15201479
references: Methods Enzymol. 2004;381:290-302
references: 15063682
references: Exp Gerontol. 2012 Nov;47(11):887-91
references: 22796225
references: Stroke. 1991 Dec;22(12):1562-6
references: 1962332
references: Neurochem Res. 2001 Sep;26(8-9):1079-84
references: 11699934
references: Brain Res. 1994 Apr 18;643(1-2):324-7
references: 7518331
references: J Biol Chem. 1999 Mar 5;274(10):6483-92
references: 10037741
references: Int J Neurosci. 1997 Nov;92(1-2):79-93
references: 9522258
references: J Neurosurg. 2000 Nov;93(5):821-8
references: 11059664
references: Brain Res. 1999 Feb 6;818(1):168-70
references: 9914452
references: Ann N Y Acad Sci. 1988;522:698-706
references: 3288065
references: J Alzheimers Dis. 2009;16(2):225-33
references: 19221414
references: Cell Calcium. 2010 Feb;47(2):165-74
references: 20116097
references: Psychiatr Clin North Am. 1991 Jun;14(2):461-82
references: 2062728
references: Neurobiol Aging. 2008 Feb;29(2):306-8
references: 17101196
references: Br J Pharmacol. 2012 Mar;165(5):1572-83
references: 21883149
references: Neuropharmacology. 2010 Sep-Oct;59(4-5):334-42
references: 20650285
references: J Pharm Pharmacol. 2006 Sep;58(9):1289-94
references: 16945189
references: J Neurochem. 2005 Nov;95(3):834-47
references: 16135089
references: Lancet. 2001 Jan 20;357(9251):169-75
references: 11213093
references: Clin Ther. 1993 Mar-Apr;15(2):394-406
references: 8519047